Niagen Bioscience Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Niagen Bioscience Inc in the second quarter 2026?
Niagen Bioscience Inc achieved a return on average equity (ROE) of 20.5 % in its second quarter 2026, this is above NAGE's average return on equity of -69.5%.
Niagen Bioscience Inc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $78 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Legal Cannabis industry only one company had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 511 to 512.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	28.56 %	48.76 %	66.04 %	105.64 %	-
Y / Y Net Income Change	-73.32 %	24.79 %	-42.44 %	143.77 %	-
Net Income (TTM) in Millions	16	19	17	20	18
Return On Equity (TTM)	20.5 %	25.38 %	26.06 %	34.58 %	35.46 %
NAGE's Total Ranking	# 512	# 511	# 323	# 272	# 235
Equity (TTM) in Millions	83	82	77	71	64
Seq. Equity Change	0.24 %	7.57 %	8.29 %	10.1 %	15.99 %
Seq. Net Income Change	-84.76 %	52.9 %	-9.74 %	26.85 %	-28.72 %

Back to NAGE Management Effectiveness >> NAGE's 5 Years Annual ROE >> Compare NAGE ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 2
Sector	# 24
Overall	# 512

Return On Equity Statistics
High	Average	Low
35.46 %	-69.5 %	-230.01 %
(Jun 30 2025)		(Sep 29 2012)

NAGE Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	77	46	28	29	32
Y / Y Equity Change	66.04 %	61.98 %	-0.75 %	-9.63 %	93.17 %
Net Income in Millions	17	9	-5	-17	-27
Y / Y Net Income Change	103.3 %	-	-	-	-
Return On Equity	22.71 %	18.55 %	-17.35 %	-57.69 %	-85.5 %

Back to NAGE Management Effectiveness >> NAGE's 5 Years Annual ROE >> Compare NAGE ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 22.71 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Legal Cannabis Industry Roe Trends and Statistics
Consumer Non Cyclical Sector Return On Equity Statistics
NAGE's' Return on Equity at Yahoo Finance
NAGE's Roe Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NAGE's Competitors
Subscribers only: Roe for Niagen Bioscience Inc 's Suppliers
Subscribers only: Return On Equity for NAGE's Customers

Companies with similar Return On Equity at Jun 30 2026, within Consumer Non Cyclical Sector	ROE
Pepsico Inc	50.13 %
CN Healthy Food Tech Group Corp.	44.61 %
Hershey Co	32.20 %
The Vita Coco Company Inc	31.09 %
Cf Industries Holdings inc	30.63 %
Procter and Gamble Co	30.05 %
Monster Beverage Corp	24.96 %
Mccormick and Company Incorporated	24.51 %
Axil Brands Inc	24.29 %
Constellation Brands Inc	23.69 %
United guardian Inc	22.24 %
Ecolab Inc	21.51 %
Niagen Bioscience Inc	20.50 %
The Marzetti Company	18.62 %
Interparfums Inc	18.60 %
Brown forman Corporation	17.90 %
Church and Dwight Co Inc	17.78 %
Mama s Creations Inc	17.30 %
Freshpet Inc	16.83 %
Seneca Foods Corporation	16.82 %
Sanfilippo John B and Son Inc	16.61 %
Coffee Holding Co Inc	16.37 %
Lamb Weston Holdings Inc	16.16 %
Smithfield Foods Inc	15.79 %
Kenvue Inc	15.58 %
Turning Point Brands Inc	15.20 %
Pilgrim s Pride Corporation	14.80 %
Andersons Inc	13.93 %
Ennis Inc	13.93 %
Ingredion Incorporated	13.70 %

Date modified: 2026-09-12T06:13:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.